Low-income patients more likely to take blood pressure medication when doctor involves them in conversation

Circulation: Quality and Outcomes Report

Low-income patients with high blood pressure whose healthcare providers did not use collaborative communication styles or ask about social issues, such as employment and housing, were less likely to take their blood pressure medications as directed.

Low-income black patients were least likely to take their medication when social issues weren’t discussed.

Embargoed until 3 p.m. CT / 4 p.m. ET Tuesday, August 22, 2017

DALLAS, August 22, 2017 — The key to getting low-income patients to take their blood pressure medications as prescribed may be as simple as a conversation. Low-income patients with high blood pressure were less likely to take their medications as directed when their healthcare providers did not use a collaborative communication style or ask them about social issues such as employment, housing and partner relationships, according to new research in the American Heart Association’s journal Circulation: Quality and Outcomes.

Patients not taking high blood pressure medication as directed plays a major role in the continued problem of poorly controlled high blood pressure, a significant risk factor for heart attacks and strokes. Researchers found that patients were three times less likely to take their high blood pressure medications when their providers did not possess a collaborative communication style such as asking open-ended questions and checking their understanding of instructions. Patients were also six times less likely to take their medications as prescribed when a healthcare provider did not ask them about social issues such as employment, housing and partner relationships.

“When healthcare providers ask patients about life challenges or take the time to check their patient’s understanding of instructions, it signals that their healthcare provider genuinely cares about them and provides the motivation and confidence to manage their health issues on their own,” said Antoinette Schoenthaler, Ed.D., lead author for the study and an associate professor of medicine at NYU School of Medicine in New York City.

The researchers audiotaped interactions between 92 patients and 27 providers over a three-month period from three practices that serve a multi-ethnic, low-income population in New York City. One office visit for each patient was audiotaped.

The majority of the patients were black, unemployed and reported some college education. Fifty-eight percent of patients were women and most were seeing the same provider for at least one year. The providers (56 percent white; 67 percent women) have been in practice for an average of 5.8 years. The researchers measured whether patients took their medications during the three-month study period through the use of an electronic monitoring device that recorded the time and date each time they opened the pill bottle.

The researchers found striking differences in medication adherence between the black and white patients. Overall, black patients were more likely to have poor adherence to their blood pressure medications compared to white patients. Moreover, compared to the overall patient population, non-adherence was more pronounced with black patients when social issues were not discussed (eight times less likely to take medication as prescribed compared to six).

“Healthcare providers should talk to patients about the things that get in the way of taking their medication, such as relationship status, employment and housing. Unemployment, for example, affects whether patients can afford medication, which is a primary risk factor for non-adherence. If these issues go undiscussed, healthcare providers may never figure out why patients are not taking their medications,” said Schoenthaler.

She suggested healthcare providers work with community health workers, nurses or medical assistants, to help identify resources for patients who have difficulty taking their medications.

Co-authors are George J. Knafl, Ph.D., Kevin Fiscella, M.D. and Gbenga Ogedegbe, M.D.Author disclosures are on the manuscript.

For updates and new science from Circulation Quality and Outcomes, follow @CircOutcomes

###

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at www.heart.org/corporatefunding.

About the American Heart Association

The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.